Predict your next investment

Family Office
FINANCE | Investment Banking
crownpredator.com

See what CB Insights has to offer

Investments

4

Portfolio Exits

1

About Crown Predator Holdings

Crown Predator Holdings (CPH) invests in early and growth stage companies with an interest in special situations that do not easily fit into traditional investment categories. CPH leads and co-invests in transactions across all industries, capital structures, and styles. Through an extensive and global network of relationships and support, CPH seeks to add value as partners, not just as investors. Founded in 2006 and based in New York City, CPH is a family office led investment firm.

Crown Predator Holdings Headquarter Location

221 East 59th Street 2nd Floor

New York, New York, 10022,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Crown Predator Holdings Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Crown Predator Holdings Rank

Latest Crown Predator Holdings News

Establishment Labs Raises $20M

Sep 18, 2015

Establishment Labs Raises $20M 9/17/15 Establishment Labs, the next generation breast aesthetics company, today announced the closing of a new round of financing in excess of $20 Million led by Crown Predator Holdings and JW Asset Management. “Our mission is to make breast aesthetics safer and better for women worldwide by delivering a world class technology platform that promotes women’s health and enables the strategic adoption of Motiva as the brand of choice in the market,” said Juan José Chacón-Quirós, CEO of Establishment Labs. “The investment and partnership from Crown Predator and JW Asset Management and the global relationships and experience they provide will enable us to accelerate investment in our technology, grow our customer base, and scale our business to meet growing demand. We are excited to officially begin the journey to bring our next generation Motiva implants to the United States, the largest market for breast aesthetics in the world.” Today, thousands of patients and plastic surgeons in over 50 countries and across five continents are choosing Motiva implants that include exclusive capabilities like RFID microtransponders, fully biocompatible nanosurfaces, and TrueTissue™ dynamics for the look and feel of natural breasts, and an extended product guarantee through Lloyd’s of London. Motiva implants have reported complication rates of less than 1% after 5 years of implantation. “We see tremendous opportunities in the breast aesthetics market. After spending significant time analyzing the space and meeting with leading plastic surgeons, we found Motiva to be the leading technology brand that meets the demands of health-conscious women worldwide”, said Nick Lewin, Managing Partner at Crown Predator Holdings. “Women deserve to have the best minds, both doctors and scientists, working on breast implant technology, and have a product that incorporates all the advancements in medical devices, surface technology, and silicon innovation over the past 25 years. Jason Wild, President and Chief Investment Officer at JW Asset Management added, “The team at Establishment Labs is focused on delivering the highest quality products in the industry, including an advanced technology platform to provide a first class customer experience. Establishment Labs is poised to become a market leader in breast aesthetics and we are excited to be a part of this round of financing.” About Establishment Labs Establishment Labs is a global, privately held, aesthetic company that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast ( http://www.motivaimplants.com ) and body shaping implants. Utilizing only the highest quality of medical grade silicones, the CE-marked Motiva Implant Matrix® line is rigorously scrutinized by professional Quality Engineers throughout the entire manufacturing process. All of its products are manufactured in full compliance with ISO and EU requirements, and are certified under the Medical Device Directive 93/42/EEC. About Crown Predator Holdings Crown Predator Holdings (CPH) invests in early and growth stage companies with an interest in special situations that do not easily fit into traditional investment categories. CPH leads and co-invests in transactions across all industries, capital structures, and styles. Through an extensive and global network of relationships and support, CPH seeks to add value as partners, not just as investors. Founded in 2006 and based in New York City, CPH is a family office led investment firm. About JW Asset Management JW Asset Management is a New York based fund manager for five investment partnerships. Jason Wild, a registered pharmacist, is the firm’s founder and chief investment officer. JW Asset Management was founded in 1997 and has a strong history of finding opportunities within the specialty pharmaceutical sector. The firm is active in both the public and private equity markets. Stories you Need to Know Stories you Need to Know It's on us. Share your news here.

Crown Predator Holdings Investments

4 Investments

Crown Predator Holdings has made 4 investments. Their latest investment was in Establishment Labs as part of their Unattributed - II on September 9, 2015.

CBI Logo

Crown Predator Holdings Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/18/2015

Unattributed - II

Establishment Labs

$20M

Yes

1

4/10/2014

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Other Investors

Subscribe to see more

Subscribe to see more

0

Other Investors

Subscribe to see more

Subscribe to see more

0

Date

9/18/2015

4/10/2014

Round

Unattributed - II

Series B

Other Investors

Other Investors

Company

Establishment Labs

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$20M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

0

0

Crown Predator Holdings Portfolio Exits

1 Portfolio Exit

Crown Predator Holdings has 1 portfolio exit. Their latest portfolio exit was Establishment Labs on July 19, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/19/2018

IPO

$99M

Public

1

Date

7/19/2018

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

1

Crown Predator Holdings Team

1 Team Member

Crown Predator Holdings has 1 team member, including current Managing Director, Shawn Canter.

Name

Work History

Title

Status

Shawn Canter

Managing Director

Current

Name

Shawn Canter

Work History

Title

Managing Director

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.